Primary immunodeficiency syndromes

Advances in Experimental Medicine and Biology

Volumn 685, Issue , 2010, Pages 146-165

  Slatter, Mary A ^b   Gennery, Andrew R ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ANTIBIOTIC AGENT; BUTADIENE DIEPOXIDE; DNA DEPENDENT PROTEIN KINASE; DNA LIGASE 4; DNA LIGASE I; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN RECEPTOR; MISMATCH REPAIR PROTEIN PMS2; MITOMYCIN C; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAD50 PROTEIN; RAG1 PROTEIN; RAG2 PROTEIN; RECOMBINASE; UNCLASSIFIED DRUG; URACIL DNA GLYCOSIDASE;

ACTIVATION INDUCED CYTIDINE DEAMINASE DEFICIENCY; ADAPTIVE IMMUNITY; ARTEMIS DEFICIENCY; ARTICLE; ATAXIA TELANGIECTASIA; BLOOM SYNDROME; CERNUNNOS XLF DEFICIENCY; DNA DAMAGE; DNA LIGASE 4 DEFICIENCY; DNA PK DEFICIENCY; DNA REPAIR; GENE REARRANGEMENT; GENETIC DISORDER; GENETIC RECOMBINATION; HUMAN; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; MOLECULAR DYNAMICS; MSH5 DEFICIENCY; NIJMEGEN BREAKAGE SYNDROME; PMS2 DEFICIENCY; PRIORITY JOURNAL; RAD50 DEFICIENCY; RIDDLE SYNDROME; SOMATIC HYPERMUTATION; URACIL DNA GLYCOSIDASE DEFICIENCY; ANIMAL; DISORDERS OF DNA SYNTHESIS AND REPAIR; DNA REPLICATION; FEMALE; GENETICS; GENOMIC INSTABILITY; IMMUNOLOGY; MALE; METABOLISM; MUTATION; RADIATION DOSE; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; DNA REPAIR; DNA REPAIR-DEFICIENCY DISORDERS; DNA REPLICATION; FEMALE; GENE REARRANGEMENT, T-LYMPHOCYTE; GENOMIC INSTABILITY; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MUTATION; RADIATION TOLERANCE; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 77955903640     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6448-9_14     Document Type: Article

References (144)

1. Lieber MR, Ma Y, Pannicke U et al. The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination. DNA Repair (Amst) 2004; 3:817-826. (Pubitemid 39004089)
2. Riballo E, Kuhne M, Rief N et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis and proteins locating to gamma-H2AX foci. Mol Cell 2004; 16:715-724. (Pubitemid 39586530)
3. Bredemeyer AL, Sharma GG, Huang CY et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 2006; 442:466-470. (Pubitemid 44264797)
4. Huang CY, Sharma GG, Walker LM et al. Defects in coding joint formation in vivo in developing ATM-deficient B- and T-lymphocytes. J Exp Med 2007; 204:1371-1381. (Pubitemid 46919875)
5. Helmink BA, Bredemeyer AL, Lee BS et al. MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks. J Exp Med 2009; 206:669-679.
6. Perkins EJ, Nair A, Cowley DO et al. Sensing of intermediates in V(D)J recombination by ATM. Genes Dev 2002; 16:159-164.
7. Chen HT, Bhandoola A, Difilippantonio MJ et al. Response to RAG-mediated VDJ cleavage by NBS1 andα-H2AX. Science 2000; 290:1962-1965.
8. Celeste A, Fernandez-Capetillo O, Kruhlak MJ et al. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol 2003; 5:675-679. (Pubitemid 36818091)
9. Stracker TH, Theunissen JW, Morales M et al. The Mre11 complex and the metabolism of chromosome breaks: The importance of communicating and holding things together. DNA Repair (Amst) 2004; 3:845-854. (Pubitemid 38997926)
10. Difilippantonio S, Celeste A, Fernandez-Capetillo O et al. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat Cell Biol 2005; 7:675-685. (Pubitemid 40975748)
11. Kobayashi Y, Tycko B, Soreng AL et al. Transrearrangements between antigen receptor genes in normal human lymphoid tissues and in ataxia telangiectasia. J Immunol 1991; 147:3201-3209.
12. Corneo B, Wendland RL, Deriano L et al. Rag mutations reveal robust alternative end joining. Nature 2007; 449:483-486. (Pubitemid 47509551)
13. Iwasato T, Shimizu A, Honjo T et al. Circular DNA is excised by immunoglobulin class switch recombination. Cell 1990; 62:143-149.
14. Muramatsu M, Kinoshita K, Fagarasan S et al. Class switch recombination and hypermutation require activation- induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102:553-563.
15. Revy P, Muto T, Levy Y et al. Activation-Induced cytidine Deaminase (AID) deficiency causes the autosomal recessive form of Hyper-IgM syndrome (HIGM2). Cell 2000; 102:565-575.
16. Bransteitter R, Pham P, Scharff MD et al. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc Natl Acad Sci USA 2003; 100:4102-4107. (Pubitemid 36418164)
17. Rada C, Williams GT, Nilsen H et al. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol 2002; 12:1748-1755. (Pubitemid 35169790)
18. Guikema JE, Linehan EK, Tsuchimoto D et al. APE1- and APE2-dependent DNA breaks in immunoglobulin class switch recombination. J Exp Med 2007; 204:3017-3026. (Pubitemid 350182393)
19. Xue K, Rada C, Neuberger MS. The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/- ung-/- mice. J Exp Med 2006; 203:2085-2094. (Pubitemid 44352230)
20. Wilson TM, Vaisman A, Martomo SA et al. MSH2-MSH6 stimulates DNA polymerase eta, suggesting a role for A:T mutations in antibody genes. J Exp Med 2005; 201:637-645. (Pubitemid 40289553)
21. Matsuoka S, Ballif BA, Smogorzewska A et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160-1166. (Pubitemid 46877472)
22. Schrader CE, Vardo J, Stavnezer J. Role for mismatch repair proteins Msh2, Mlh1 and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J Exp Med 2002; 195:367-373. (Pubitemid 34461495)
23. Péron S, Metin A, Gardés P et al. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J Exp Med 2008; 205:2465-2472.
24. Babbe H, Chester N, Leder P et al. The Bloom's syndrome helicase is critical for development and function of the alphabeta T-cell lineage. Mol Cell Biol 2007; 27:1947-1959.
25. Pedrazzi G, Bachrati CZ, Selak N et al. The Bloom's syndrome helicase interacts directly with the human DNA mismatch repair protein hMSH6. Biol Chem 2003; 384:1155-1164. (Pubitemid 37121188)
26. Pedrazzi G, Perrera C, Blaser H et al. Direct association of Bloom's syndrome gene product with the human mismatch repair protein MLH1. Nucleic Acids Res 2001; 29:4378-4386. (Pubitemid 33064778)
27. Schrader CE, Guikema JE, Linehan EK et al. Activation-induced cytidine deaminase-dependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. J Immunol 2007; 179:6064-6071.
28. Yan CT, Boboila C, Souza EK et al. IgH class switching and translocations use a robust nonclassical end-joining pathway. Nature 2007; 449:478-482. (Pubitemid 47509538)
29. Berkovich E, Monnat RJ Jr, Kastan MB. Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair. Nat Cell Biol 2007; 9:683-690. (Pubitemid 47214731)
30. Burma S, Chen BP, Murphy M et al. ATM phosphorylates histone H2AX in response to DNA double- strand breaks. J Biol Chem 2001; 276:42462-42467.
31. Kobayashi J, Tauchi H, Chen B et al. Histone H2AX participates the DNA damage-induced ATM activation through interaction with NBS1. Biochem Biophys Res Commun 2009; 380:752-757.
32. Ward IM, Reina-San-Martin B, Olaru A et al. 53BP1 is required for class switch recombination. J Cell Biol 2004; 165:459-464. (Pubitemid 38679611)
33. Rooney S, Alt FW, Sekiguchi J et al. Artemis-independent functions of DNA-dependent protein kinase in Ig heavy chain class switch recombination and development. Proc Natl Acad Sci USA 2005; 102:2471-2475. (Pubitemid 40279400)
34. Franco S, Murphy MM, Li G et al. DNA-PKcs and Artemis function in the end-joining phase of immunoglobulin heavy chain class switch recombination. J Exp Med 2008; 205:557-564. (Pubitemid 351439303)
35. Du L, van der Burg M, Popov SW et al. Involvement of Artemis in nonhomologous end-joining during immunoglobulin class switch recombination. J Exp Med 2008; 205:3031-3040.
36. Pan-Hammarstrom Q, Jones AM, Lahdesmaki A et al. Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells. J Exp Med 2005; 201:189-194. (Pubitemid 40189427)
37. Helleday T, Bryant HE, Schultz N. Poly (ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy. Cell Cycle 2005; 4:1176-1178. (Pubitemid 41365386)
38. Audebert M, Salles B, Calsou P. Involvement of poly (ADP-ribose) polymerase-1 and XRCC1/ DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem 2004; 279:55117-55126. (Pubitemid 40066505)
39. Wang H, Rosidi B, Perrault R et al. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res 2005; 65:4020-30. (Pubitemid 40775638)
40. Robert I, Dantzer F, Reina-San-Martin B. Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination. J Exp Med 2009; 206:1047-1056.
41. Liang L, Deng L, Nguyen SC et al. Human DNA ligases I and III, but not ligase IV, are required for microhomology- mediated end joining of DNA double-strand breaks. Nucleic Acids Res 2008; 36:3297-3310. (Pubitemid 351858999)
42. Sekine H, Ferreira RC, Pan-Hammarström Q et al. Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci USA 2007; 104:7193-7198. (Pubitemid 47186031)
43. Kaartinen M, Griffiths GM, Markham AF et al. mRNA sequences define an unusually restricted IgG response to 2-phenyloxazolone and its early diversification. Nature 1983; 304:320-324. (Pubitemid 13072751)
44. Storb U. Progress in understanding the mechanism and consequences of somatic hypermutation. Immunol Rev 1998; 162:5-11.
45. Shivarov V, Shinkura R, Doi T et al. Molecular mechanism for generation of antibody memory. Philos Trans R Soc Lond B Biol Sci 2009; 364:569-575.
46. Schanz S, Castor D, Fischer F et al. Interference of mismatch and base excision repair during the processing of adjacent U/G mispairs may play a key role in somatic hypermutation. Proc Natl Acad Sci USA 2009; 106:5593-5598.
47. Larson ED, Cummings WJ, Bednarski DW et al. MRE11/RAD50 cleaves DNA in the AID/ UNG-dependent pathway of immunoglobulin gene diversification. Mol Cell 2005; 20:367-375. (Pubitemid 41572294)
48. Sack SZ, Liu Y, German J et al. Somatic hypermutation of immunoglobulin genes is independent of the Bloom's syndrome DNA helicase. Clin Exp Immunol 1998; 112:248-254. (Pubitemid 28266683)
49. Schwarz K, Glaus GH, Ludwig L et al. RAG mutations in human B-cell-negative SCID. Science 1996; 274:97-99. (Pubitemid 26332732)
50. Villa A, Santagata S, Bozzi F et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998; 93:885-896. (Pubitemid 28257593)
51. Omenn GS. Familial reticuloendotheliosis with eosinophilia. N Engl J Med 1965; 273:427-432.
52. Rieux-Laucat F, Bahadoran P, Brousse N et al. Highly restricted human T-cell repertoire beta (TCRB) chain diversity in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrom (severe combined immunodeficiency with hypereosinophilia). J Clin Invest 1998; 102:312-321. (Pubitemid 28335190)
53. Ehl S, Schwarz K, Enders A et al. A variant of SCID with specific immune responses and predominance of gamma delta T-cells. J Clin Invest 2005; 115:3140-3148. (Pubitemid 41567578)
54. de Villartay JP, Lim A, Al-Mousa H et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest 2005; 115:3291-3299. (Pubitemid 41567594)
55. Schuetz C, Huck K, Gudowius S et al. An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med 2008; 358:2030-2038. (Pubitemid 351656457)
56. Moshous D, Callebaut I, de Chasseval R et al. Artemis, a novel DNA double-strand break repair/ V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 2001; 105:177-186. (Pubitemid 32429508)
57. Jones JF, Ritenbaugh CK, Spence MA et al. Severe combined immunodeficiency among the Navajo. I. Characterization of phenotypes, epidemiology and population genetics. Hum Biol 1991; 63:669-682.
58. Cavazzana-Calvo M, Le Deist F, de Saint Basile G et al. Increased radiosensitivity of granulocyte macrophage colony-forming units and skin fibroblasts in human autosomal recessive severe combined immunodeficiency. J Clin Invest 1993; 91:1214-1218. (Pubitemid 23095301)
59. Ege M, Ma Y, Manfras B et al. Omenn syndrome due to ARTEMIS mutations. Blood 2005; 105:4179-4186. (Pubitemid 40720760)
60. Moshous D, Pannetier C, de Chasseval R et al. Partial T- and B-lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest 2003; 111:381-387. (Pubitemid 36182215)
61. Evans PM, Woodbine L, Riballo E et al. Radiation-induced delayed cell death in a hypomorphic Artemis cell line. Hum Mol Genet 2006; 15:1303-1311.
62. van der Burg M, Ijspeert H, Verkaik NS et al. A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining. J Clin Invest 2009; 119:91-98.
63. Riballo E, Critchlow SE, Teo SH et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol 1999; 9:699-702. (Pubitemid 29332352)
64. O'Driscoll M, Cerosaletti KM, Girard PM et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 2001; 8:1175-1185. (Pubitemid 34084990)
65. Unal S, Cerosaletti K, Uckan-Cetinkaya D et al. A novel mutation in a family with DNA ligase IV deficiency syndrome. Pediatr Blood Cancer 2009; 53:482-484.
66. van der Burg M, van Veelen LR, Verkaik NS et al. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest 2006; 116:137-145. (Pubitemid 43121798)
67. Buck D, Moshous D, de Chasseval R et al. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur J Immunol 2006; 36:224-235. (Pubitemid 43116409)
68. Ben-Omran TI, Cerosaletti K, Concannon P et al. A patient with mutations in DNA Ligase IV: Clinical features and overlap with Nijmegen breakage syndrome. Am J Med Genet A 2005; 137:283-287. (Pubitemid 41262661)
69. Enders A, Fisch P, Schwarz K et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol 2006; 176:5060-5068.
70. Toita N, Hatano N, Ono S et al. Epstein-Barr virus-associated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. Am J Med Genet A 2007; 143:742-745. (Pubitemid 46606685)
71. Grunebaum E, Bates A, Roifman CM. Omenn syndrome is associated with mutations in DNA ligase IV. J Allergy Clin Immunol 2008; 122:1219-1220.
72. Buck D, Malivert L, de Chasseval R et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 2006; 124:287-299. (Pubitemid 43121978)
73. Ahnesorg P, Smith P, Jackson SP. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 2006; 124:301-313. (Pubitemid 43121979)
74. Dai Y, Kysela B, Hanakahi LA et al. Nonhomologous end joining and V(D)J recombination require an additional factor. Proc Natl Acad Sci USA 2003; 100:2462-2467. (Pubitemid 36297521)
75. Faraci M, Lanino E, Micalizzi C et al. Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency. Pediatr Transplant 2008. [Epub ahead of print].
76. Schwartz M, Oren YS, Bester AC et al. Impaired replication stress response in cells from immunodeficiency patients carrying Cernunnos/XLF mutations. PLoS One 2009; 4:e4516.
77. Ahmad SI, ed. Molecular mechanisms of ataxia telangiectasis. medical intelligence unit, Landes Bioscience Publication, Texas, 2009.
78. Noordzij JG, Wulffraat NM, Haraldsson A et al. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome. Arch Dis Child 2009; 94:448-449.
79. Lefton-Greif MA, Crawford TO, Winkelstein JA et al. Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr 2000; 136:225-231. (Pubitemid 30470995)
80. Staples ER, McDermott EM, Reiman A et al. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol 2008; 153:214-220. (Pubitemid 351989158)
81. Sanal O, Ersoy F, Yel L et al. Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia. J Clin Immunol 1999; 19:326-334. (Pubitemid 29489399)
82. Tangsinmankong N, Wayne AS, Howenstine M et al. Lymphocytic interstitial pneumonitis, elevated IgM concentration and hepatosplenomegaly in ataxia-telangiectasia. J Pediatr 2001; 138:939-941. (Pubitemid 32545608)
83. Srisirirojanakorn N, Finegold MJ, Gopalakrishna GS et al. Hepatic veno-occlusive disease in ataxia-telangiectasia. J Pediatr 1999; 134:786-788. (Pubitemid 30186829)
84. Crawford TO, Skolasky RL, Fernandez R et al. Survival probability in ataxia telangiectasia. Arch Dis Child 2006; 91:610-611. (Pubitemid 44023364)
85. Giovannetti A, Mazzetta F, Caprini E et al. Skewed T-cell receptor repertoire, decreased thymic output and predominance of terminally differentiated T-cells in ataxia telangiectasia. Blood 2002; 100:4082-4089. (Pubitemid 35396876)
86. Reina-San-Martin B, Chen HT, Nussenzweig A et al. ATM is required for efficient recombination between immunoglobulin switch regions. J Exp Med 2004; 200:1103-1110. (Pubitemid 39507050)
87. Weemaes CM, Hustinx TW, Scheres JM et al. A new chromosomal instability disorder: The Nijmegen breakage syndrome. Acta Paediatr Scand 1981; 70:557-564. (Pubitemid 11078625)
88. Digweed M, Sperling K. Nijmegen breakage syndrome: Clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst) 2004; 3:1207-1217. (Pubitemid 38997964)
89. Gregorek H, Chrzanowska KH, Michalkiewicz J et al. Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: An 8-year follow-up study in a single centre. Clin Exp Immunol 2002; 130:319-324. (Pubitemid 35286221)
90. Xu Y. ATM in lymphoid development and tumorigenesis. Adv Immunol 1999; 72:179-189. (Pubitemid 30224826)
91. Kracker S, Bergmann Y, Demuth I et al. Nibrin functions in Ig class-switch recombination. Proc Natl Acad Sci USA 2005; 102:1584-1589. (Pubitemid 40209211)
92. Reina-San-Martin B, Nussenzweig MC, Nussenzweig A et al. Genomic instability, endoreduplication and diminished Ig class-switch recombination in B-cells lacking Nbs1. Proc Natl Acad Sci USA 2005; 102:1590-1595. (Pubitemid 40209212)
93. Wolf EK, Shwayder TA. Nijmegen breakage syndrome associated with porokeratosis. Pediatr Dermatol 2009; 26:106-8.
94. Yoo J, Wolgamot G, Torgerson TR et al. Cutaneous noncaseating granulomas associated with Nijmegen breakage syndrome. Arch Dermatol 2008; 144:418-419. (Pubitemid 351439136)
95. Green AM, Kupfer GM. Fanconi anemia. Hematol Oncol Clin North Am 2009; 23:193-214.
96. Ahmad SI, Kirk SH, eds. Molecular Mechanisms of Fanconi anemia. Austin: Landes Bioscience, 2006.
97. Gennery AR, Slatter MA, Bhattacharya A et al. The clinical and biological overlap between Nijmegen Breakage Syndrome and Fanconi anemia. Clin Immunol 2004; 113:214-219. (Pubitemid 39296855)
98. Stewart GS, Maser RS, Stankovic T et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 1999; 99:577-587. (Pubitemid 30004634)
99. Delia D, Piane M, Buscemi G et al. MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder. Hum Mol Genet 2004; 13:2155-2163. (Pubitemid 39377837)
100. Fernet M, Gribaa M, Salih MA et al. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum Mol Genet 2005; 14:307-318.
101. Khan AO, Oystreck DT, Koenig M et al. Ophthalmic features of ataxia telangiectasia-like disorder. J AAPOS 2008; 12:186-189.
102. Taylor AM, Groom A, Byrd PJ. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair (Amst) 2004; 3:1219-1225. (Pubitemid 38997965)
103. Lahdesmaki A, Taylor AM, Chrzanowska KH et al. Delineation of the role of the Mre11 complex in class switch recombination. J Biol Chem 2004; 279:16479-16487. (Pubitemid 38509346)
104. Waltes R, Kalb R, Gatei M et al. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am J Hum Genet 2009; 84:605-616.
105. Barbi G, Scheres JM, Schindler D et al. Chromosome instability and X-ray hypersensitivity in a microcephalic and growth-retarded child. Am J Med Genet 1991; 40:44-45.
106. Donahue SL, Tabah AA, Schmitz K et al. Defective signal joint recombination in fanconi anemia fibroblasts reveals a role for Rad50 in V(D)J recombination. J Mol Biol 2007; 370:449-458. (Pubitemid 46901069)
107. Stewart GS, Stankovic T, Byrd PJ et al. RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling. Proc Natl Acad Sci USA 2007; 104:16910-16915. (Pubitemid 350210964)
108. Stewart GS, Panier S, Townsend K et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 2009; 136:420-434.
109. Difilippantonio S, Gapud E, Wong N et al. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 2008; 456:529-533. (Pubitemid 50304846)
110. Manis JP, Morales JC, Xia Z et al. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat Immunol 2004; 5:481-487. (Pubitemid 38660459)
111. Ward IM, Reina-San-Martin B, Olaru A et al. 53BP1 is required for class switch recombination. J Cell Biol 2004; 165:459-464. (Pubitemid 38679611)
112. Berardinelli F, di Masi A, Salvatore M et al. A case report of a patient with microcephaly, facial dysmorphism, chromosomal radiosensitivity and telomere length alterations closely resembling "Nijmegen breakage syndrome" phenotype. Eur J Med Genet 2007; 50:176-187. (Pubitemid 46765252)
113. Maraschio P, Spadoni E, Tanzarella C et al. Genetic heterogeneity for a Nijmegen breakage-like syndrome. Clin Genet 2003; 63:283-290. (Pubitemid 36949934)
114. Hiel JA, Weemaes CM, van Engelen BG et al. Nijmegen breakage syndrome in a Dutch patient not resulting from a defect in NBS1. J Med Genet 2001; 38:E19.
115. Revy P, Muto T, Levy Y et al. Activation-Induced cytidine Deaminase (AID) deficiency causes the autosomal recessive form of Hyper-IgM syndrome (HIGM2). Cell 2000; 102:565-575.
116. Quartier P, Bustamante J, Sanal O et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin Immunol 2004; 110:22-29. (Pubitemid 38177417)
117. Minegishi Y, Lavoie A, Cunningham-Rundles C et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 2000; 97:203-210.
118. Hase K, Takahashi D, Ebisawa M et al. Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease. PLoS One 2008; 3:e3033.
119. Ta VT, Nagaoka H, Catalan N et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 2003; 4:843-848. (Pubitemid 37098654)
120. Imai K, Zhu Y, Revy P et al. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. Clin Immunol 2005; 115:277-285. (Pubitemid 40712323)
121. Imai K, Slupphaug G, Lee WI et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 2003; 4:1023-1028. (Pubitemid 37265924)
122. De Vos M, Hayward BE, Charlton R et al. PMS2 mutations in childhood cancer. J Natl Cancer Inst 2006; 98:358-361. (Pubitemid 43338216)
123. Kratz CP, Niemeyer CM, Jüttner E et al. Childhood T-cell non-Hodgkin's lymphoma, colorectal carcinoma and brain tumor in association with café-au-lait spots caused by a novel homozygous PMS2 mutation. Leukemia 2008; 22:1078-1080. (Pubitemid 351689897)
124. Imai K, Catalan N, Plebani A et al. Hyper-IgM syndrome type 4 with a B-lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 2003; 112:136-142. (Pubitemid 38056385)
125. Péron S, Pan-Hammarström Q, Imai K et al. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair. J Exp Med 2007; 204:1207-1216. (Pubitemid 46798162)
126. Durandy A. Immunoglobulin class switch recombination: Study through human natural mutants. Philos Trans R Soc Lond B Biol Sci 2009; 364:577-582.
127. Webster AD, Barnes DE, Arlett CF et al. Growth retardation and immunodeficiency in a patient with mutations in the DNA ligase I gene. Lancet 1992; 339:1508-1509.
128. Barnes DE, Tomkinson AE, Lehmann AR et al. Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell 1992; 69:495-503.
129. Soza S, Leva V, Vago R et al. DNA ligase I deficiency leads to replication-dependent DNA damage and impacts cell morphology without blocking cell cycle progression. Mol Cell Biol 2009; 29:2032-2041.
130. Petrini JH, Donovan JW, Dimare C et al. Normal V(D)J coding junction formation in DNA ligase I deficiency syndromes. J Immunol 1994; 152:176-178.
131. Vago R, Leva V, Biamonti G et al. DNA ligase I and Nbs1 proteins associate in a complex and colocalize at replication factories. Cell Cycle 2009; 8(16). [Epub ahead of print].
132. Hütteroth TH, Litwin SD, German J. Abnormal immune responses of Bloom's syndrome lymphocytes in vitro. J Clin Invest 1975; 56:1-7.
133. Van Kerckhove CW, Ceuppens JL, Vanderschueren-Lodeweyckx M et al. Bloom's syndrome. Clinical features and immunologic abnormalities of four patients. Am J Dis Child 1988; 142:1089-1093.
134. German J. Bloom's syndrome. Dermatol Clin 1995; 13:7-18.
135. Kondo N, Ozawa T, Kato Y et al. Reduced secreted mu mRNA synthesis in selective IgM deficiency of Bloom's syndrome. Clin Exp Immunol 1992; 88:35-40.
136. Taniguchi N, Mukai M, Nagaoki T et al. Impaired B-cell differentiation and T-cell regulatory function in four patients with Bloom's syndrome. Clin Immunol Immunopathol 1982; 22:247-258. (Pubitemid 12223046)
137. Hsieh CL, Arlett CF, Lieber MR. V(D)J recombination in ataxia telangiectasia, Bloom's syndrome and a DNA ligase I-associated immunodeficiency disorder. J Biol Chem 1993; 268:20105-20109. (Pubitemid 23278908)
138. Babbe H, Chester N, Leder P et al. The Bloom's syndrome helicase is critical for development and function of the alphabeta T-cell lineage. Mol Cell Biol 2007; 27:1947-1959.
139. Babbe H, McMenamin J, Hobeika E et al. Genomic instability resulting from Blm deficiency compromises development, maintenance and function of the B-cell lineage. J Immunol 2009; 182:347-360.
140. Gruhn B, Seidel J, Zintl F et al. Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure. Orphanet J Rare Dis 2007; 2:5.
141. Albert MH, Gennery AR, Greil J et al. Successful Stem cell transplantation for Nijmegen breakage syndrome. Bone Marrow Transplant 2009 (in press).
142. Dembowska-Baginska B, Perek D, Brozyna A et al. Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS). Pediatr Blood Cancer 2009; 52:186-190.
143. Benjelloun F, Garrigue A, Demerens-de Chappedelaine C et al. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells. Mol Ther 2008; 16:1490-1499.
144. Lai CH, Chun HH, Nahas SA et al. Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. Proc Natl Acad Sci USA 2004; 101:15676-15681. (Pubitemid 39473547)